Evaluation of Hematological and Biochemical Parameters that Predict the No-reflow Phenomenon in Patients Undergoing

Selim Aydemir1, Sidar Şiyar Aydın2, Onur Altınkaya1

  • 1Department of Cardiology, Erzurum City Hospital, University of Health Sciences, Erzurum, Turkey.

Angiology
|February 17, 2025
PubMed

Insights

Predicting the no-reflow phenomenon (NRP) after primary percutaneous coronary intervention (pPCI) in acute coronary syndromes (ACS) is crucial. Routine blood tests like hemoglobin and white blood cell count can help identify patients at risk before treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Biochemistry

Background:

  • Acute coronary syndromes (ACS) are a leading cause of death globally.
  • Primary percutaneous coronary intervention (pPCI) is standard treatment for ACS to restore blood flow.
  • The no-reflow phenomenon (NRP) can impede successful reperfusion despite pPCI.

Purpose of the Study:

  • To identify and compare parameters that predict the occurrence of NRP in ACS patients undergoing pPCI.
  • To evaluate the predictive value of common hematological and biochemical markers for NRP.

Main Methods:

  • Retrospective analysis of 5122 ACS patients.
  • Cox regression and Receiver Operating Characteristic (ROC) curve analysis were used.
  • Identified independent predictors of NRP.

Main Results:

  • NRP occurred in 1.8% of patients.
  • Age, hemoglobin (Hb), white blood cell (WBC) count, glucose, and low-density lipoprotein cholesterol (LDL-C) were independent predictors of NRP.
  • WBC count demonstrated the highest predictive power (AUC: 0.605).

Conclusions:

  • Simple, routinely measured hematological and biochemical parameters can predict NRP risk in ACS patients before pPCI.
  • Early identification of NRP risk can potentially improve patient management and outcomes.